<ul><li>Sattva Sukun Lifecare Limited received in-principle approval from the Bombay Stock Exchange for its proposed rights issue.</li><li>The company aims to raise Rs 49.50 Crore through the rights issue.</li><li>The net proceeds will be used to meet working capital requirements, support business expansion, and invest in existing subsidiaries.</li><li>The company reported a 65% increase in revenue and 126% growth in net profit for the nine-month period ended December 2024.</li></ul>

BSE Grants In Principle Approval To Sattva Sukun Lifecare For Rights Issue Up To Rs 49.50 Cr

Discover more